Isofra, spray, 15 ml
Manufacturer: Bouchard Laboratory, France
$30.00
| Active ingredient: | |
|---|---|
| Dosage form: | |
| Indications for use: |
Indications
Indications
As part of combination therapy for infectious and inflammatory diseases of the upper respiratory tract, including:
- Rhinitis.
- Rhinopharyngitis.
- Sinusitis (in the absence of damage to the septum).
Prevention and treatment of inflammatory processes after surgical interventions.
Dosage
How to take, course of administration and dosage
For adults: assign 1 injection in each nostril 4-6 times a day.
For children: assign 1 injection in each nostril 3 times a day.
The average duration of therapy is 7 days.
When used, the bottle should be kept in an upright position.
Contraindications
Contraindications
Hypersensitivity to framycetin and other aminoglycoside antibiotics.
Composition
Composition
of 1 ml of nasal spray solution contains:
Active substance:
framycetin sulfate – 12.5 mg (8 thous. IU).
Excipients:
methyl parahydroxybenzoate,
sodium chloride,
citric acid,
distilled water.
Composition
>
1 ml of nasal spray solution contains:
Active ingredient:
framycetin sulfate – 12.5 mg (8 thous. IU).
Auxiliary substances:
methyl parahydroxybenzoate,
sodium chloride,
citric acid,
distilled water.
Pharmacological action
Pharmacological action – broad-spectrum antibacterial, bactericidal, antibacterial.
Damages the cytoplasmic membrane of a microbial cell, disorganizes the flow of metabolites inside it with rapid subsequent death.
Framycetin
is a bactericidal antibiotic for topical application from the group of aminoglycosides.
The concentration of framycetin achieved with topical application ensures its bactericidal activity against gram-positive and gram-negative microorganisms, pathogens of infectious processes in the upper respiratory tract.
Indications
As part of combination therapy for infectious and inflammatory diseases of the upper respiratory tract, including:
- Rhinitis.
- Rhinopharyngitis.
- Sinusitis (in the absence of damage to the septum).
Prevention and treatment of inflammatory processes after surgical interventions.
Use during pregnancy and lactation
Adequate and strictly controlled clinical studies of the safety of using the drug Isofra during pregnancy and lactation (breastfeeding) have not been conducted.
Contraindications
Hypersensitivity to framycetin and other aminoglycoside antibiotics.
Side effects
Allergic reactions: in isolated cases – skin manifestations.
Interaction
No clinically significant interactions of the drug Isofra with other drugs were detected.
How to take, course of administration and dosage
For adults: assign 1 injection in each nostril 4-6 times a day.
For children: assign 1 injection in each nostril 3 times a day.
The average duration of therapy is 7 days.
When used, the bottle should be kept in an upright position.
Overdose
Due to the low degree of absorption into the systemic circulation, overdose is unlikely.
Special instructions
If the therapeutic effect is absent or weak within 7 days of treatment, the drug should be discontinued.
Form of production
Nasal spray
Storage conditions
At a temperature not exceeding 25 °C
Shelf life
3 years
Active ingredient
Framycetin
Conditions of release from pharmacies
By prescription
Dosage Form
Spray nasal
Weight
Weight: 30 gr.
Best price for Isofra, spray, 15 ml in our online pharmacy!
Side effects of Isofra, spray, 15 ml.
Related products
Reviews
There are no reviews yet.